Tandem Diabetes Care
TNDM
TNDM
317 hedge funds and large institutions have $2.97B invested in Tandem Diabetes Care in 2024 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 124 increasing their positions, 92 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 291 → 317 (+26)
1.05% more ownership
Funds ownership: 112.95% → 114% (+1.1%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
317
Holding in Top 10
2
Calls
$135M
Puts
$15.3M
Top Buyers
| 1 | +$76.2M | |
| 2 | +$50M | |
| 3 | +$27.7M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$27.3M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$105M | |
| 2 | -$30.2M | |
| 3 | -$29.3M | |
| 4 |
Jennison Associates
New York
|
-$23.6M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$19.7M |